Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Lam

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Clinical Therapeutics|September 20, 2017
Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-oldsIra Gantz, Liubov Sokolova, Lokesh Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volumeAndrea G Rockall, Norbert Avril, Raymond Lam, et al.
Tissue Engineering. Part A|July 25, 2019
Synergistic Effect of NELL-1 and an Ultra-Low Dose of BMP-2 on Spinal FusionLing Liu, Wing Moon Raymond Lam, Mathanapriya Naidu, et al.
Chempluschem|January 22, 2020
Zwitterionic Modification of Ultrasmall Iron Oxide Nanoparticles for Reduced Protein Corona FormationKarina Pombo-García, Carmen L Rühl, Raymond Lam, et al.
Stem Cell Research & Therapy|June 7, 2025
Unveiling the potential of MSC extracellular vesicles: MiR-122-5p enhancing chondrocyte regeneration in osteoarthritis via autophagy mechanismHaifeng Zhang, Yanmeng Yang, Yingnan Wu, et al.
The Spine Journal : Official Journal of the North American Spine Society|October 15, 2021
Paraspinal myopathy-induced intervertebral disc degeneration and thoracolumbar kyphosis in TSC1mKO mice model-a preliminary studyHwee Weng Dennis Hey, Wing Moon Raymond Lam, Chloe Xiaoyun Chan, et al.
Spine|June 16, 2023
Systemic Diclofenac Sodium Reduces Postoperative rhBMP-2 Induced Neuroinflammation: A Rodent Model StudyGlen Liau Zi Qiang, Sherry Liu Jiani, Wing Moon Raymond Lam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid TumorsAndrew J Wagner, Udai Banerji, Amit Mahipal, et al.
Leukemia Research|August 22, 2016
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)Farhad Ravandi, Ivana Gojo, Mrinal M Patnaik, et al.
Cytotherapy|May 5, 2025
Shaping the future of cell and gene therapy workforce development: training of cell therapy processing personnel - perspectives from the International Society for Cell & Gene Therapy Lab Practices CommitteeElena Maryamchik, Ashley Krull, Yvette C Tanhehco, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Clinical Therapeutics|September 20, 2017
Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-oldsIra Gantz, Liubov Sokolova, Lokesh Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volumeAndrea G Rockall, Norbert Avril, Raymond Lam, et al.
Tissue Engineering. Part A|July 25, 2019
Synergistic Effect of NELL-1 and an Ultra-Low Dose of BMP-2 on Spinal FusionLing Liu, Wing Moon Raymond Lam, Mathanapriya Naidu, et al.
Chempluschem|January 22, 2020
Zwitterionic Modification of Ultrasmall Iron Oxide Nanoparticles for Reduced Protein Corona FormationKarina Pombo-García, Carmen L Rühl, Raymond Lam, et al.
Stem Cell Research & Therapy|June 7, 2025
Unveiling the potential of MSC extracellular vesicles: MiR-122-5p enhancing chondrocyte regeneration in osteoarthritis via autophagy mechanismHaifeng Zhang, Yanmeng Yang, Yingnan Wu, et al.
The Spine Journal : Official Journal of the North American Spine Society|October 15, 2021
Paraspinal myopathy-induced intervertebral disc degeneration and thoracolumbar kyphosis in TSC1mKO mice model-a preliminary studyHwee Weng Dennis Hey, Wing Moon Raymond Lam, Chloe Xiaoyun Chan, et al.
Spine|June 16, 2023
Systemic Diclofenac Sodium Reduces Postoperative rhBMP-2 Induced Neuroinflammation: A Rodent Model StudyGlen Liau Zi Qiang, Sherry Liu Jiani, Wing Moon Raymond Lam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid TumorsAndrew J Wagner, Udai Banerji, Amit Mahipal, et al.
Leukemia Research|August 22, 2016
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)Farhad Ravandi, Ivana Gojo, Mrinal M Patnaik, et al.
Cytotherapy|May 5, 2025
Shaping the future of cell and gene therapy workforce development: training of cell therapy processing personnel - perspectives from the International Society for Cell & Gene Therapy Lab Practices CommitteeElena Maryamchik, Ashley Krull, Yvette C Tanhehco, et al.
Pageof 5